EXCITING PRESS

How to Get Your Face Ready for the Real World Again

How to Get Your Face Ready for the Real World Again

“How to Get Your Face Ready for the Real World Again” featuring Evoke! Evoke is a cosmetic treatment with no recovery downtime that will rejuvenate your face after a year hiding behind masks and computer screens, writes beauty editor Aja Mangum in the latest Bloomberg feature. Evoke hands-free non-invasive treatments stimulates collagen production for noticeable lifting and tightening of the skin, treating sagging jowls and loose skin under the neck while practicing physical distancing.

Is Now The Time To Put InMode On Your Watchlist?

Is Now The Time To Put InMode On Your Watchlist?

InMode’s (NASDAQ: INMD) EPS soared from US$1.85 to US$2.55 over the last year. That’s an impressive gain of 38%. Revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. InMode is growing revenues, and EBIT margins improved 40% over the last year. That’s great to see, on both counts.

I like company leaders to have some skin in the game because it increases alignment of incentives between the people running the business and its true owners. I’m encouraged by the fact that insiders own InMode shares worth a considerable sum that equates to 24% of the company, making insiders powerful and aligned with other shareholders. Very encouraging.

Read the article here.

Jim Cramer bullish on InMode (INMD) on Mad Money

Jim Cramer bullish on InMode (INMD) on Mad Money

In the Lightning Round on his Mad Money show, Jim Cramer was bullish on InMode (Nasdaq: INMD), saying the stock was “a great secular growth story; it is driven and it’s got earnings.”

View video here.

Cosmetic Procedures Paint a Pretty Picture at InMode

Cosmetic Procedures Paint a Pretty Picture at InMode

Cosmetic Procedures Paint a Pretty Picture at InMode

InMode’s business is surging despite the pandemic — or because of it? Yup, providers, aestheticians and surgeons note that people see themselves on Zoom calls for hours, and they come in to fix what they see.

InMode’s stock (Nasdaq: #INMD) has climbed 51% in the past 3 months, led by the company’s in-demand minimally, non-invasive and hands-free #technology, reports Tom Bishop, a small-cap expert and editor of BI Research. Over the last 12 months, #growth has risen InMode to #4 in the #InvestorsBusinessDaily IBD-50 with a composite rating of 98 and a strong “BI Rank” buy rating.

Read the Yahoo Finance article here.

A Multi-Bagger Stock In The Making: InMode Has All The Right Traits

A Multi-Bagger Stock In The Making: InMode Has All The Right Traits

“InMode is the best stock in the quickly growing medical aesthetic devices industry,” proclaims Stock Bros Research, adding, “this is why it has vastly outperformed its peers.” InMode (Nasdaq: INMD) is an asset-light business with high returns on capital and a flawless balance sheet with no debt. Industry demand for its technology devices remains high, seeing record revenues in Q3 2020 with a 49% YoY increase.

InMode has many qualities of a multi-bagger stock, surpassing the competition in operational efficiency and brand recognition. In addition, the company insiders have shown that they believe in the company as no shares traded hands throughout the pandemic. As a result, InMode will continue to see strong growth.

Read the article here.

How can we help?

Please select a topic below related to your inquiry.

Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us